The International Consensus Meeting on the Mode of Action of COX-2 Inhibition, 5-6 December 1997: Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2

Rheumatology

Volumn 38, Issue 8, 1999, Pages 779-788

  Brooks, P ^a   Emery, P ^b   Evans, J F ^c   Fenner, H ^d   Hawkey, C J ^e   Patrono, C ^f   Smolen, J ^g   Breedveld, F ^h   Day, R ⁱ   Dougados, M ^j   Ehrich, E W ^c   Gijon Banos J ^k   Kvien, T K ^l   Van Rijswijk, M H ^m   Warner, T ⁿ   Zeidler, H ^o  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

^d ETH ZURICH   (Switzerland)

^e NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^f UNIVERSITY OF CHIETI   (Italy)

^g GENERAL HOSPITAL LINZ   (Austria)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j Université Paris Descartes   (France)

^k University Hospital   (Spain)

^l DIAKONHJEMMET HOSPITAL   (Norway)

^m UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁿ ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^o HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

Acute pain; COX 1; COX 2 specific inhibition; COX 2 COX 1 ratios; Cyclooxygenase; Gastrointestinal safety; NSAIDs; Osteoarthritis

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

CONFERENCE PAPER; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL; BLOOD CELL; DRUG EFFECT; ENZYME SPECIFICITY; PHYSIOLOGY; TIME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD CELLS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SUBSTRATE SPECIFICITY; TIME FACTORS;

EID: 0001023001     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.8.779     Document Type: Conference Paper

References (34)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature 1971;231:232-5.
2. Smith JB, Willis AL. Aspirin selectivity inhibits prostaglandin production in human platelets. Chest 1971;59:12S.
3. Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: Structure and catalysis. Biochim Biophys Acta 1991;1083:1-17.
4. Ferreira SH. Peripheral analgesia: mechanism of the analgesic action of aspirin like drugs and opiate-antagonists. Br J Clin Pharmacol 1980;10:237S-45S.
5. Higgs GA. Arachidonic acid metabolism, pain and hyperalgesia: the mode of action of non-steroid analgesics. Br J Clin Pharmacol 1980;10:233S-5S.
6. Bunting S, Moncada S, Vane JR. The prostacyclin-thromboxane balance: pathophysiological and therapeutic considerations. Br Med Bull 1983;39:271-6.
7. Chakraborty I, Das SK, Wang J et al. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol 1996;16:107-22.
8. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993;11:371-86.
9. Kömhoff M, Gröne H-J, Klein T, Seyberth HW, Nüsing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol 1997;272:F460-8.
10. Masferrer JL, Zweifel BS, Seibert K et al. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990;86;1375-9.
11. Holtzmann MJ, Turk J, Shornick LP. Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. J Biol Chem 1992;267:21438-45.
12. Masferrer JL, Zweifel BS, Manning PT et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and non-ulcerogenic. Proc Natl Acad Sci USA 1994;91:3228-32.
13. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6.
14. Hla T, Neilson K. Human cyclooxygenase-2 DNA. Proc Natl Acad Sci USA 1992;89:7384-8.
15. Masferrer JL, Seibert K, Zweifel B, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992;89: 3917-21.
16. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclooxygenase-2 gene. Biochem J 1994;302:723-7.
17. Smith WL, DeWitt DL. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995;15:179-94.
18. Sirois J, Richards JS. Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Evidence for the role of a cis-acting C/EBP beta promoter element. J Biol Chem 1993;268:21 931-8.
19. Ristimaki A, Garfinkel S, Wessendorf J, Macaig T, Hla T. Induction of cycloxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 1994;269:11 769-75.
20. 2 synthase-1. Nature 1994;367:243-9.
21. Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nature Struct Biol 1996;11:927-33.
22. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993;268:9049-54.
23. Percival MD, Ouellet M, Vincent CJ, Yergey JA, Kennedy BP, O'Neill GP. Purification and characterization of recombinant human cyclooxygenase-2. Arch Biochem Biophys 1994;315:111-8.
24. Kurumbail RG, Stevens AM, Gierse JK et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996;384:644-8.
25. Seibert K, Zhang Y, Leahy K et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994;91:12013-7.
26. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995;55:2556-9.
27. O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993;330:156-60.
28. Kaufman WE, Worley PF, Pegg J, Bremer M, Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 1996;93:2317-21.
29. Walenga RW, Kester M, Coroneos E, Butcher S, Dwivedi R, Statt C. Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in human tracheal epithelial cells in vitro. Prostaglandins 1996; 52:341-59.
30. Iseki S. Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach. Histochem J 1995; 27:323-8.
31. O'Banion MK, Sadowski HB, Winn V, Young DA. A serum and glucocorticoid regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991;266:23 261-7.
32. Lee SH, Soyoola E, Chanmugam P et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992; 267:25 934-8.
33. DeWitt D. Prostaglandin endoperoxide synthase: Regulation of enzyme expression. Biochim Biophys Acta 1991;1083:121-34.
34. Amin AR, Attur M, Patel RN et al. Superinduction of cyclooxygenase-2 activity in human OA-affected cartilage. Influence of nitric oxide. J Clin Invest 1997;99:1231-7.